Peter Kalivas to Substance-Related Disorders
This is a "connection" page, showing publications Peter Kalivas has written about Substance-Related Disorders.
Connection Strength
8.234
-
Reply to: N-Acetylcysteine in Treatment of Substance Use Disorders. Biol Psychiatry. 2019 06 01; 85(11):e61.
Score: 0.325
-
Metaplasticity at the addicted tetrapartite synapse: A common denominator of drug induced adaptations and potential treatment target for addiction. Neurobiol Learn Mem. 2018 10; 154:97-111.
Score: 0.307
-
Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug Abuse. Int J Neuropsychopharmacol. 2017 10 01; 20(10):797-812.
Score: 0.299
-
A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders. J Clin Psychiatry. 2016 Nov; 77(11):e1439-e1446.
Score: 0.281
-
The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis. Pharmacol Rev. 2016 07; 68(3):816-71.
Score: 0.274
-
The good and bad news about glutamate in drug addiction. J Psychopharmacol. 2016 11; 30(11):1095-1098.
Score: 0.274
-
Signals from the Fourth Dimension Regulate Drug Relapse. Trends Neurosci. 2016 07; 39(7):472-485.
Score: 0.272
-
Corticostriatal circuitry in regulating diseases characterized by intrusive thinking. Dialogues Clin Neurosci. 2016 Mar; 18(1):65-76.
Score: 0.268
-
The tetrapartite synapse: Extracellular matrix remodeling contributes to corticoaccumbens plasticity underlying drug addiction. Brain Res. 2015 Dec 02; 1628(Pt A):29-39.
Score: 0.251
-
Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders. CNS Neurol Disord Drug Targets. 2015; 14(6):745-56.
Score: 0.247
-
"Mourning" a lost opportunity. Psychopharmacology (Berl). 2014 Oct; 231(19):3921-2.
Score: 0.237
-
Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis. Neuroscientist. 2014 Dec; 20(6):610-22.
Score: 0.232
-
The story of glutamate in drug addiction and of N-acetylcysteine as a potential pharmacotherapy. JAMA Psychiatry. 2013 Sep; 70(9):895-7.
Score: 0.225
-
Rapid, transient synaptic plasticity in addiction. Neuropharmacology. 2014 Jan; 76 Pt B:276-86.
Score: 0.220
-
Getting to the core of addiction: hatching the addiction egg. Nat Med. 2012 Apr 05; 18(4):502-3.
Score: 0.205
-
Substance abuse disorders. Handb Clin Neurol. 2012; 106:419-31.
Score: 0.201
-
New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol Psychiatry. 2011 Oct; 16(10):974-86.
Score: 0.192
-
Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol Rev. 2011 Jun; 63(2):348-65.
Score: 0.191
-
Using glutamate homeostasis as a target for treating addictive disorders. Behav Pharmacol. 2010 Sep; 21(5-6):514-22.
Score: 0.183
-
Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction. Eur J Pharmacol. 2010 Aug 10; 639(1-3):115-22.
Score: 0.178
-
The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009 Aug; 10(8):561-72.
Score: 0.169
-
Glutamate and reinstatement. Curr Opin Pharmacol. 2009 Feb; 9(1):59-64.
Score: 0.164
-
Addiction as a pathology in prefrontal cortical regulation of corticostriatal habit circuitry. Neurotox Res. 2008 Oct; 14(2-3):185-9.
Score: 0.160
-
Glutamate transmission in addiction. Neuropharmacology. 2009; 56 Suppl 1:169-73.
Score: 0.158
-
Brain norepinephrine rediscovered in addiction research. Biol Psychiatry. 2008 Jun 01; 63(11):1005-6.
Score: 0.157
-
Neuropharmacology of addiction--setting the scene. Br J Pharmacol. 2008 May; 154(2):259-60.
Score: 0.155
-
Microdialysis and the neurochemistry of addiction. Pharmacol Biochem Behav. 2008 Aug; 90(2):261-72.
Score: 0.149
-
Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology. 2008 Jan; 33(1):166-80.
Score: 0.149
-
Animal models and brain circuits in drug addiction. Mol Interv. 2006 Dec; 6(6):339-44.
Score: 0.141
-
Exciting inhibition in psychostimulant addiction. Trends Neurosci. 2006 Nov; 29(11):610-6.
Score: 0.139
-
Orexin: a gatekeeper of addiction. Nat Med. 2006 Mar; 12(3):274-6.
Score: 0.134
-
How do we determine which drug-induced neuroplastic changes are important? Nat Neurosci. 2005 Nov; 8(11):1440-1.
Score: 0.131
-
The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005 Aug; 162(8):1403-13.
Score: 0.129
-
Recent understanding in the mechanisms of addiction. Curr Psychiatry Rep. 2004 Oct; 6(5):347-51.
Score: 0.122
-
Novel ideas about novelty. Commentary on Badiani and Robinson drug-induced neurobehavioral plasticity: the role of environmental context. Behav Pharmacol. 2004 Sep; 15(5-6):373-6.
Score: 0.121
-
Choose to study choice in addiction. Am J Psychiatry. 2004 Feb; 161(2):193-4.
Score: 0.116
-
AGS3: a G-Protein regulator of addiction-associated behaviors. Ann N Y Acad Sci. 2003 Nov; 1003:356-7.
Score: 0.114
-
Predisposition to addiction: pharmacokinetics, pharmacodynamics, and brain circuitry. Am J Psychiatry. 2003 Jan; 160(1):1-2.
Score: 0.108
-
Extrasynaptic therapeutic targets in substance use and stress disorders. Trends Pharmacol Sci. 2022 01; 43(1):56-68.
Score: 0.099
-
Drug addiction: to the cortex.and beyond! Am J Psychiatry. 2001 Mar; 158(3):349-50.
Score: 0.095
-
Targeting redox regulation to treat substance use disorder using N-acetylcysteine Eur J Neurosci. 2019 08; 50(3):2538-2551.
Score: 0.080
-
Abstinence From Drug Dependence After Bilateral Globus Pallidus Hypoxic-Ischemic Injury. Biol Psychiatry. 2016 11 01; 80(9):e79-e80.
Score: 0.068
-
Potential role of N-acetylcysteine in the management of substance use disorders. CNS Drugs. 2014 Feb; 28(2):95-106.
Score: 0.058
-
Metabotropic glutamatergic receptors and their ligands in drug addiction. Pharmacol Ther. 2014 Jun; 142(3):281-305.
Score: 0.058
-
Cellular mechanisms of behavioral sensitization to drugs of abuse. Ann N Y Acad Sci. 1992 Jun 28; 654:128-35.
Score: 0.052
-
The role of the nucleus accumbens in sensitization to drugs of abuse. Prog Neuropsychopharmacol Biol Psychiatry. 1992 Mar; 16(2):237-46.
Score: 0.051
-
Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacol Biochem Behav. 2012 Feb; 100(4):801-10.
Score: 0.048
-
Preliminary evidence for a cocaine-induced embryopathy in mice. Toxicol Appl Pharmacol. 1990 Apr; 103(2):228-37.
Score: 0.044
-
Role of the prefrontal cortex and nucleus accumbens in reinstating methamphetamine seeking. Eur J Neurosci. 2010 Mar; 31(5):903-9.
Score: 0.044
-
Extinction circuits for fear and addiction overlap in prefrontal cortex. Learn Mem. 2009 May; 16(5):279-88.
Score: 0.042
-
Evidence for a relationship between Group 1 mGluR hypofunction and increased cocaine and ethanol sensitivity in Homer2 null mutant mice. Ann N Y Acad Sci. 2003 Nov; 1003:468-71.
Score: 0.029
-
The temporal sequence of changes in gene expression by drugs of abuse. Methods Mol Med. 2003; 79:3-11.
Score: 0.027
-
Circuit selectivity in drug versus natural reward seeking behaviors. J Neurochem. 2021 06; 157(5):1450-1472.
Score: 0.024
-
A role for sensitization in craving and relapse in cocaine addiction. J Psychopharmacol. 1998; 12(1):49-53.
Score: 0.019
-
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev. 1997 Oct; 25(2):192-216.
Score: 0.019